Fresenius Medical Care (FMS) vs Progyny (PGNY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Progyny (PGNY) has outperformed Fresenius Medical Care (FMS) over the past year, gaining 37.8% versus a loss of 22.9%. Over five years, FMS leads with a -41.7% price change compared with -50.8% for PGNY. Fresenius Medical Care is the larger company by market cap ($11.01 billion vs $2.11 billion), about 5.2 times the size.
On valuation, Fresenius Medical Care trades at a lower forward P/E (6.9x vs 11.9x for Progyny). Fresenius Medical Care pays a dividend yielding 7.20%, while Progyny does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FMS | PGNY |
|---|---|---|
| Share price | $20.69 | $27.55 |
| Market cap | $11.01B | $2.11B |
| 1-day change | -7.72% | +6.33% |
| YTD return | -13.14% | +7.28% |
| 1-year return | -22.86% | +37.75% |
| 5-year return | -41.65% | -50.79% |
| P/E ratio (TTM) | 11.56 | 29.95 |
| Forward P/E | 6.92 | 11.88 |
| EPS (TTM) | $1.79 | $0.92 |
| Dividend yield | 7.20% | 0.00% |
| Annual dividend | $1.49 | $0.00 |
| Revenue (latest FY) | $4.97B | — |
| Revenue growth (YoY) | -63.98% | — |
| Net income (latest FY) | $1.11B | — |
| Gross margin | 95.33% | — |
| Operating margin | 45.39% | — |
| Net margin | 22.33% | — |
| 52-week high | $27.64 | $33.07 |
| 52-week low | $20.02 | $16.10 |
| Distance from 52-week high | -25.14% | -16.68% |
| Analyst consensus | hold | none |
| Avg. price target upside | +13.24% | +24.94% |
| Average volume | 696.44K | 1.13M |
| Shares outstanding | 532.22M | 76.73M |
| Employees | 107,226 | 835 |
| Sector | Health Care | Health Care |
| Industry | Misc Health and Biotechnology Services | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Fresenius Medical Care is about 5.2 times larger than Progyny by market value ($11.01B vs $2.11B).
- PGNY has outperformed FMS by 60.6 percentage points over the past year.
- Progyny trades at a higher earnings multiple (29.9x vs 11.6x trailing P/E).
- Fresenius Medical Care offers a meaningfully higher dividend yield (7.20% vs 0.00%).
About Fresenius Medical Care
FMS stock →Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Health Care · Misc Health and Biotechnology Services · 107,226 employees
About Progyny
PGNY stock →Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists.
Health Care · Misc Health and Biotechnology Services · 835 employees
FMS vs PGNY FAQ
Which is bigger, Fresenius Medical Care or Progyny?
Fresenius Medical Care (FMS) is larger, with a market capitalization of $11.01B compared with $2.11B for Progyny (PGNY).
Which stock has performed better over the past year, FMS or PGNY?
PGNY returned +37.75% over the past 12 months, compared with -22.86% for FMS (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, FMS or PGNY?
FMS has the lower trailing P/E at 11.6, versus 29.9 for PGNY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Fresenius Medical Care or Progyny?
Fresenius Medical Care pays a dividend yielding 7.20%, while Progyny does not currently pay a regular dividend.
Are Fresenius Medical Care and Progyny in the same industry?
Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.